| Thanks
to Lead SoCalBio Sponsors
|
 |
Looking
for Legal Help with IP Matters or
Business Transactions?
|
|
|
|
Take
Advantage of SoCalBio's Group
Purchasing Program to Cut the Cost of
Doing Business
Newest Addition
Diversified
Alarm Services
For security applications
including access control, video
surveillance, burglar and fire alarms
with 24 hour UL monitoring. For more
information, contact Daniel Johnson at
800-252-7652 or send e-mail to: alarmla@aol.com
|
| Recommended
Events
BioEngineering Insights
2009
------------------------------
-------
|
Register
Now
|
Join
SoCalBio
Join well-known entrepreneur
Alfred Mann and other SoCalBio leaders
to promote the biotech and device
industries in the Greater Los Angeles Metro
Area for job creation and overall
economic growth.
|
 |
|
|
|
Apply Now
to Make a Presentation at the SoCalBio
Investor/Partnership Conference
|
Is
your firm an innovative advanced medical
technology or biotech company interested
in raising capital, partnering your
products or technologies, or initiating
strategic alliances? If so, apply now
for a company presentation slot during
the 11th SoCalBio Investor and
Partnership Conference on Sep. 17, 2009
at the Loews Hotel in Santa Monica. Send
an executive summary
|
|
SoCalBio Business
Mixers
|
-
August 27,
7:00 - 9:30 am
-
 SoCalBio
Networking Forum in Irvine (UCI
University Club)
Focus: Meeting
Pricing and Reimbursement Challenges
for Pharma and Device Companies
in a Changing Healthcare System ... More
Info
- September
30, 4:00 - 7:00 pm
-
SoCalBio
Networking Forum in Ventura
County (Westlake Village Inn)
Focus: Innovation
and Protecting Your Intellectual
Property in a Changing Patent Regime
... More
Info
|
| New
SoCalBio Member |
Biological Test
Center
Preclinical
contract research organization.
For more info, contact Dr. Stacy
Pritt at 949-660-2412 or send
e-mail to stacy.pritt@bbraun.com
|
| From
The Lab Bench |
Crystal Ball For Brain Cancer?
New UCLA Research Predicts Which Brain
Tumors Will Respond To Drug
UCLA
researchers have uncovered a new way
to scan brain tumors and predict which
ones will be shrunk by the drug
Avastin -- before the patient ever
starts treatment. By linking high
water movement in tumors to positive
drug response, the UCLA team predicted
with 70 percent accuracy which
patients' tumors were the least likely
to grow six months after therapy .... Learn
more
UCLA
Scientists Identify How Immune Cells May
Help Predict Alzheimer's Risk; MP
Biomedicals Granted Rights to Further
Develop Screening Tool
UCLA scientists have discovered a way
to measure the amount of amyloid beta
that is being absorbed by immune cells
in the blood. Amyloid beta forms the
plaques considered the hallmark of
Alzheimer's disease, and if the immune
system isn't adequately clearing
amyloid beta, it may indicate
Alzheimer's risk, according to the
researchers. Milan Panic's MP
Biomedicals LLC, a diagnostics
company dedicated to Alzheimer's
disease research, has received an
exclusive, worldwide license to
commercialize the UCLA technology and
create a diagnostic blood test for
public use to screen for Alzheimer's
risk ... Read
more
|
| Technology
Acquisition |
|
Spectrum
Pharmaceuticals Acquires Full Rights
and Intellectual Property for RenaZorb
for All Fields of Use
"While focused on the oncology
field, we remain opportunistic with
our other value-driving assets such as
RenaZorb, a drug candidate with the
potential to reduce dosage burden for
chronic kidney disease patients and
enable more effective management of
their disease," said Rajesh C.
Shrotriya, MD, Chairman, Chief
Executive Officer, and President of
the Irvine-based Spectrum
Pharmaceuticals .... Read
more
|
| Partnership |
|
Palm
Desert-Based Medical Technologies
International (MTI) and NASA Johnson
Space Center (JSC) Partner on
Cardiovascular Testing Initiative for
Astronauts and Trainees
JSC will utilize MTI's ArterioVision
test, a unique tool that enables
physicians to safely and accurately
detect early warning signs of
cardiovascular disease. The
ArterioVision procedure was developed
using the same imaging technology that
NASA originally employed to detect the
presence of ice on Mars. Read
more
|
| IP
Litigation |
|
ICU
Medical, Inc. and Medegen, Inc.
Announce Resolution of Patent
Litigation
The two companies are shifting
their focus from the litigation to
business relationship.... Read
more
|
| Clinical
Studies |
|
Results
from a Phase 2 Study of ABRAXANE In
Combination With Carboplatin Show
Clinical Activity in the First Line
Treatment of Patients with Advanced
Non-Small Cell Lung Cancer
"The results from this phase 2
study show clinical activity that
could offer promise in the treatment
of this hard-to-treat cancer. Data
from this phase 2 investigation across
multiple dose and administration
schedules of ABRAXANE led to the
decision to initiate a phase 3 trial
to further study ABRAXANE for the
treatment of NSCLC. The Phase 3 trial
is ongoing and includes 1,050 patients
from 111 sites globally," said
José Iglesias, M.D., Chief Medical
Officer and VP, Global Clinical
Development of Abraxis Bioscience ... Read
more
|
| Financing |
|
MannKind
closes public stock offering, says net
proceeds are $59.7 million
The Valencia-based biotech company
announced the closing of the public
offering of 7,400,000 shares of its
common stock. MannKind's chairman,
chief executive officer and principal
stockholder, Alfred E. Mann, is
purchasing 1,000,000 of these shares
from the underwriters. Jefferies &
Co. was the bookrunning manager of the
offering, and Rodman & Renshaw was
the co-manager.... Read
more
|
| Product
Launch |
|
San
Pedro-Based Celprogen Launches Human
Triple Negative Breast Cancer Stem
Cells
Celprogen's Breast Cancer Stem Cells
are characterized by estrogen,
progesterone and HER2 receptor
negative and are very aggressive
tumors with poor prognosis. The Triple
Negative Breast Cancer Parental and
Cancer Stem cells together with their
high through put cell based assay kits
provides basic science research and
drug discovery programs to screen and
design novel drug candidates for
treatment of patients with this type
of cancer ... Read
more
|
| Product
Recall |
|
Watson
Pharmaceuticals of Corona Recalls
Painkilling Fentanyl Patch
The company said some of the patches
leak fentanyl gel, which could expose
patients or caregivers to the drug
directly. It said no injuries have
been reported, but exposure to the gel
could cause difficulty breathing or a
possible overdose ... Read
more
|
| Hot
Jobs |
-
Pango Medical Devices (San
Diego) -- a device contract
manufacturer in San Diego -- is
looking to fill the position of Marketing
Coordinator ... Click
here for details and to apply
-
ChromoLogic (Pasadena)
is seeking to fill these positions:
-
Research Scientist
-
Research Engineer
-
Research Intern
-
OrthAlign --
a medical device company in Irvine
-- is seeking to fill the position
of VP of Operations ... Click
here for details and to apply
For more jobs, sign up to access
SoCalBio's LinkedIn Page
|
|
About SoCalBio
|
 SoCalBio
membership links you to partners,
contract manufacturers, regulatory and
legal experts, and policy makers. The
organization's programs help emerging
biotech and medical device companies
grow. Membership is affordable -- as
low as $500 -- and offers access to
networking opportunities, advocacy,
discounts through our group purchasing
program group
purchasing program and
other benefits you simply can't find
elsewhere ... Join
SoCalBio
|
|
|
Editor:
